Global Human Prothrombin Complex Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Human Prothrombin Complex market size is predicted to grow from US$ 2129 million in 2025 to US$ 4258 million in 2031; it is expected to grow at a CAGR of 12.2% from 2025 to 2031.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
LP Information, Inc. (LPI) ' newest research report, the “Human Prothrombin Complex Industry Forecast” looks at past sales and reviews total world Human Prothrombin Complex sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Prothrombin Complex sales for 2025 through 2031. With Human Prothrombin Complex sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Prothrombin Complex industry.
This Insight Report provides a comprehensive analysis of the global Human Prothrombin Complex landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Prothrombin Complex portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Prothrombin Complex market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Prothrombin Complex and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Prothrombin Complex.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Prothrombin Complex market?
What factors are driving Human Prothrombin Complex market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Prothrombin Complex market opportunities vary by end market size?
How does Human Prothrombin Complex break out by Type, by Application?
The global Human Prothrombin Complex market size is predicted to grow from US$ 2129 million in 2025 to US$ 4258 million in 2031; it is expected to grow at a CAGR of 12.2% from 2025 to 2031.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
LP Information, Inc. (LPI) ' newest research report, the “Human Prothrombin Complex Industry Forecast” looks at past sales and reviews total world Human Prothrombin Complex sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Prothrombin Complex sales for 2025 through 2031. With Human Prothrombin Complex sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Prothrombin Complex industry.
This Insight Report provides a comprehensive analysis of the global Human Prothrombin Complex landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Prothrombin Complex portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Prothrombin Complex market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Prothrombin Complex and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Prothrombin Complex.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
- Hemophilia B
- Vitamin K Deficiency
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
What is the 10-year outlook for the global Human Prothrombin Complex market?
What factors are driving Human Prothrombin Complex market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Prothrombin Complex market opportunities vary by end market size?
How does Human Prothrombin Complex break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Prothrombin Complex Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Prothrombin Complex by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Prothrombin Complex by Country/Region, 2020, 2024 & 2031
2.2 Human Prothrombin Complex Segment by Type
2.2.1 500 IU/Vial
2.2.2 600 IU/Vial
2.2.3 1000 IU/Vial
2.2.4 Others
2.3 Human Prothrombin Complex Sales by Type
2.3.1 Global Human Prothrombin Complex Sales Market Share by Type (2020-2025)
2.3.2 Global Human Prothrombin Complex Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Prothrombin Complex Sale Price by Type (2020-2025)
2.4 Human Prothrombin Complex Segment by Application
2.4.1 Hemophilia B
2.4.2 Vitamin K Deficiency
2.4.3 Others
2.5 Human Prothrombin Complex Sales by Application
2.5.1 Global Human Prothrombin Complex Sale Market Share by Application (2020-2025)
2.5.2 Global Human Prothrombin Complex Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Prothrombin Complex Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Prothrombin Complex Breakdown Data by Company
3.1.1 Global Human Prothrombin Complex Annual Sales by Company (2020-2025)
3.1.2 Global Human Prothrombin Complex Sales Market Share by Company (2020-2025)
3.2 Global Human Prothrombin Complex Annual Revenue by Company (2020-2025)
3.2.1 Global Human Prothrombin Complex Revenue by Company (2020-2025)
3.2.2 Global Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
3.3 Global Human Prothrombin Complex Sale Price by Company
3.4 Key Manufacturers Human Prothrombin Complex Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Prothrombin Complex Product Location Distribution
3.4.2 Players Human Prothrombin Complex Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN PROTHROMBIN COMPLEX BY GEOGRAPHIC REGION
4.1 World Historic Human Prothrombin Complex Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Prothrombin Complex Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Prothrombin Complex Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Prothrombin Complex Market Size by Country/Region (2020-2025)
4.2.1 Global Human Prothrombin Complex Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Prothrombin Complex Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Prothrombin Complex Sales Growth
4.4 APAC Human Prothrombin Complex Sales Growth
4.5 Europe Human Prothrombin Complex Sales Growth
4.6 Middle East & Africa Human Prothrombin Complex Sales Growth
5 AMERICAS
5.1 Americas Human Prothrombin Complex Sales by Country
5.1.1 Americas Human Prothrombin Complex Sales by Country (2020-2025)
5.1.2 Americas Human Prothrombin Complex Revenue by Country (2020-2025)
5.2 Americas Human Prothrombin Complex Sales by Type (2020-2025)
5.3 Americas Human Prothrombin Complex Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Prothrombin Complex Sales by Region
6.1.1 APAC Human Prothrombin Complex Sales by Region (2020-2025)
6.1.2 APAC Human Prothrombin Complex Revenue by Region (2020-2025)
6.2 APAC Human Prothrombin Complex Sales by Type (2020-2025)
6.3 APAC Human Prothrombin Complex Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Prothrombin Complex by Country
7.1.1 Europe Human Prothrombin Complex Sales by Country (2020-2025)
7.1.2 Europe Human Prothrombin Complex Revenue by Country (2020-2025)
7.2 Europe Human Prothrombin Complex Sales by Type (2020-2025)
7.3 Europe Human Prothrombin Complex Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Prothrombin Complex by Country
8.1.1 Middle East & Africa Human Prothrombin Complex Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Prothrombin Complex Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Prothrombin Complex Sales by Type (2020-2025)
8.3 Middle East & Africa Human Prothrombin Complex Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Prothrombin Complex
10.3 Manufacturing Process Analysis of Human Prothrombin Complex
10.4 Industry Chain Structure of Human Prothrombin Complex
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Prothrombin Complex Distributors
11.3 Human Prothrombin Complex Customer
12 WORLD FORECAST REVIEW FOR HUMAN PROTHROMBIN COMPLEX BY GEOGRAPHIC REGION
12.1 Global Human Prothrombin Complex Market Size Forecast by Region
12.1.1 Global Human Prothrombin Complex Forecast by Region (2026-2031)
12.1.2 Global Human Prothrombin Complex Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Prothrombin Complex Forecast by Type (2026-2031)
12.7 Global Human Prothrombin Complex Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Human Prothrombin Complex Product Portfolios and Specifications
13.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Prothrombin Complex Product Portfolios and Specifications
13.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Human Prothrombin Complex Product Portfolios and Specifications
13.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Human Prothrombin Complex Product Portfolios and Specifications
13.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Hualan Biological
13.5.1 Hualan Biological Company Information
13.5.2 Hualan Biological Human Prothrombin Complex Product Portfolios and Specifications
13.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hualan Biological Main Business Overview
13.5.5 Hualan Biological Latest Developments
13.6 Meheco Xinxing Pharma
13.6.1 Meheco Xinxing Pharma Company Information
13.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolios and Specifications
13.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Meheco Xinxing Pharma Main Business Overview
13.6.5 Meheco Xinxing Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Prothrombin Complex Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Prothrombin Complex by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Prothrombin Complex by Country/Region, 2020, 2024 & 2031
2.2 Human Prothrombin Complex Segment by Type
2.2.1 500 IU/Vial
2.2.2 600 IU/Vial
2.2.3 1000 IU/Vial
2.2.4 Others
2.3 Human Prothrombin Complex Sales by Type
2.3.1 Global Human Prothrombin Complex Sales Market Share by Type (2020-2025)
2.3.2 Global Human Prothrombin Complex Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Prothrombin Complex Sale Price by Type (2020-2025)
2.4 Human Prothrombin Complex Segment by Application
2.4.1 Hemophilia B
2.4.2 Vitamin K Deficiency
2.4.3 Others
2.5 Human Prothrombin Complex Sales by Application
2.5.1 Global Human Prothrombin Complex Sale Market Share by Application (2020-2025)
2.5.2 Global Human Prothrombin Complex Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Prothrombin Complex Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Prothrombin Complex Breakdown Data by Company
3.1.1 Global Human Prothrombin Complex Annual Sales by Company (2020-2025)
3.1.2 Global Human Prothrombin Complex Sales Market Share by Company (2020-2025)
3.2 Global Human Prothrombin Complex Annual Revenue by Company (2020-2025)
3.2.1 Global Human Prothrombin Complex Revenue by Company (2020-2025)
3.2.2 Global Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
3.3 Global Human Prothrombin Complex Sale Price by Company
3.4 Key Manufacturers Human Prothrombin Complex Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Prothrombin Complex Product Location Distribution
3.4.2 Players Human Prothrombin Complex Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN PROTHROMBIN COMPLEX BY GEOGRAPHIC REGION
4.1 World Historic Human Prothrombin Complex Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Prothrombin Complex Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Prothrombin Complex Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Prothrombin Complex Market Size by Country/Region (2020-2025)
4.2.1 Global Human Prothrombin Complex Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Prothrombin Complex Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Prothrombin Complex Sales Growth
4.4 APAC Human Prothrombin Complex Sales Growth
4.5 Europe Human Prothrombin Complex Sales Growth
4.6 Middle East & Africa Human Prothrombin Complex Sales Growth
5 AMERICAS
5.1 Americas Human Prothrombin Complex Sales by Country
5.1.1 Americas Human Prothrombin Complex Sales by Country (2020-2025)
5.1.2 Americas Human Prothrombin Complex Revenue by Country (2020-2025)
5.2 Americas Human Prothrombin Complex Sales by Type (2020-2025)
5.3 Americas Human Prothrombin Complex Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Prothrombin Complex Sales by Region
6.1.1 APAC Human Prothrombin Complex Sales by Region (2020-2025)
6.1.2 APAC Human Prothrombin Complex Revenue by Region (2020-2025)
6.2 APAC Human Prothrombin Complex Sales by Type (2020-2025)
6.3 APAC Human Prothrombin Complex Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Prothrombin Complex by Country
7.1.1 Europe Human Prothrombin Complex Sales by Country (2020-2025)
7.1.2 Europe Human Prothrombin Complex Revenue by Country (2020-2025)
7.2 Europe Human Prothrombin Complex Sales by Type (2020-2025)
7.3 Europe Human Prothrombin Complex Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Prothrombin Complex by Country
8.1.1 Middle East & Africa Human Prothrombin Complex Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Prothrombin Complex Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Prothrombin Complex Sales by Type (2020-2025)
8.3 Middle East & Africa Human Prothrombin Complex Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Prothrombin Complex
10.3 Manufacturing Process Analysis of Human Prothrombin Complex
10.4 Industry Chain Structure of Human Prothrombin Complex
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Prothrombin Complex Distributors
11.3 Human Prothrombin Complex Customer
12 WORLD FORECAST REVIEW FOR HUMAN PROTHROMBIN COMPLEX BY GEOGRAPHIC REGION
12.1 Global Human Prothrombin Complex Market Size Forecast by Region
12.1.1 Global Human Prothrombin Complex Forecast by Region (2026-2031)
12.1.2 Global Human Prothrombin Complex Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Prothrombin Complex Forecast by Type (2026-2031)
12.7 Global Human Prothrombin Complex Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Human Prothrombin Complex Product Portfolios and Specifications
13.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Prothrombin Complex Product Portfolios and Specifications
13.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Human Prothrombin Complex Product Portfolios and Specifications
13.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Human Prothrombin Complex Product Portfolios and Specifications
13.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Hualan Biological
13.5.1 Hualan Biological Company Information
13.5.2 Hualan Biological Human Prothrombin Complex Product Portfolios and Specifications
13.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hualan Biological Main Business Overview
13.5.5 Hualan Biological Latest Developments
13.6 Meheco Xinxing Pharma
13.6.1 Meheco Xinxing Pharma Company Information
13.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolios and Specifications
13.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Meheco Xinxing Pharma Main Business Overview
13.6.5 Meheco Xinxing Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Prothrombin Complex Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Prothrombin Complex Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 500 IU/Vial
Table 4. Major Players of 600 IU/Vial
Table 5. Major Players of 1000 IU/Vial
Table 6. Major Players of Others
Table 7. Global Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 8. Global Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Table 9. Global Human Prothrombin Complex Revenue by Type (2020-2025) & ($ million)
Table 10. Global Human Prothrombin Complex Revenue Market Share by Type (2020-2025)
Table 11. Global Human Prothrombin Complex Sale Price by Type (2020-2025) & (M USD/Unit)
Table 12. Global Human Prothrombin Complex Sale by Application (2020-2025) & (K Units)
Table 13. Global Human Prothrombin Complex Sale Market Share by Application (2020-2025)
Table 14. Global Human Prothrombin Complex Revenue by Application (2020-2025) & ($ million)
Table 15. Global Human Prothrombin Complex Revenue Market Share by Application (2020-2025)
Table 16. Global Human Prothrombin Complex Sale Price by Application (2020-2025) & (M USD/Unit)
Table 17. Global Human Prothrombin Complex Sales by Company (2020-2025) & (K Units)
Table 18. Global Human Prothrombin Complex Sales Market Share by Company (2020-2025)
Table 19. Global Human Prothrombin Complex Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 21. Global Human Prothrombin Complex Sale Price by Company (2020-2025) & (M USD/Unit)
Table 22. Key Manufacturers Human Prothrombin Complex Producing Area Distribution and Sales Area
Table 23. Players Human Prothrombin Complex Products Offered
Table 24. Human Prothrombin Complex Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Human Prothrombin Complex Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Human Prothrombin Complex Sales Market Share Geographic Region (2020-2025)
Table 29. Global Human Prothrombin Complex Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Human Prothrombin Complex Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Human Prothrombin Complex Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Human Prothrombin Complex Sales Market Share by Country/Region (2020-2025)
Table 33. Global Human Prothrombin Complex Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Human Prothrombin Complex Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)
Table 36. Americas Human Prothrombin Complex Sales Market Share by Country (2020-2025)
Table 37. Americas Human Prothrombin Complex Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 39. Americas Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 40. APAC Human Prothrombin Complex Sales by Region (2020-2025) & (K Units)
Table 41. APAC Human Prothrombin Complex Sales Market Share by Region (2020-2025)
Table 42. APAC Human Prothrombin Complex Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 44. APAC Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 45. Europe Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)
Table 46. Europe Human Prothrombin Complex Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 48. Europe Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Prothrombin Complex Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Human Prothrombin Complex
Table 54. Key Market Challenges & Risks of Human Prothrombin Complex
Table 55. Key Industry Trends of Human Prothrombin Complex
Table 56. Human Prothrombin Complex Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Human Prothrombin Complex Distributors List
Table 59. Human Prothrombin Complex Customer List
Table 60. Global Human Prothrombin Complex Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Human Prothrombin Complex Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Human Prothrombin Complex Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Human Prothrombin Complex Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Human Prothrombin Complex Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Human Prothrombin Complex Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Human Prothrombin Complex Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Human Prothrombin Complex Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Human Prothrombin Complex Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Human Prothrombin Complex Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Human Prothrombin Complex Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Human Prothrombin Complex Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Human Prothrombin Complex Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Human Prothrombin Complex Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Takeda Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 75. Takeda Human Prothrombin Complex Product Portfolios and Specifications
Table 76. Takeda Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 77. Takeda Main Business
Table 78. Takeda Latest Developments
Table 79. CSL Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 80. CSL Human Prothrombin Complex Product Portfolios and Specifications
Table 81. CSL Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 82. CSL Main Business
Table 83. CSL Latest Developments
Table 84. Grifols Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 85. Grifols Human Prothrombin Complex Product Portfolios and Specifications
Table 86. Grifols Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 87. Grifols Main Business
Table 88. Grifols Latest Developments
Table 89. Octapharma Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 90. Octapharma Human Prothrombin Complex Product Portfolios and Specifications
Table 91. Octapharma Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 92. Octapharma Main Business
Table 93. Octapharma Latest Developments
Table 94. Hualan Biological Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 95. Hualan Biological Human Prothrombin Complex Product Portfolios and Specifications
Table 96. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 97. Hualan Biological Main Business
Table 98. Hualan Biological Latest Developments
Table 99. Meheco Xinxing Pharma Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 100. Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolios and Specifications
Table 101. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 102. Meheco Xinxing Pharma Main Business
Table 103. Meheco Xinxing Pharma Latest Developments
Table 1. Human Prothrombin Complex Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Prothrombin Complex Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 500 IU/Vial
Table 4. Major Players of 600 IU/Vial
Table 5. Major Players of 1000 IU/Vial
Table 6. Major Players of Others
Table 7. Global Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 8. Global Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Table 9. Global Human Prothrombin Complex Revenue by Type (2020-2025) & ($ million)
Table 10. Global Human Prothrombin Complex Revenue Market Share by Type (2020-2025)
Table 11. Global Human Prothrombin Complex Sale Price by Type (2020-2025) & (M USD/Unit)
Table 12. Global Human Prothrombin Complex Sale by Application (2020-2025) & (K Units)
Table 13. Global Human Prothrombin Complex Sale Market Share by Application (2020-2025)
Table 14. Global Human Prothrombin Complex Revenue by Application (2020-2025) & ($ million)
Table 15. Global Human Prothrombin Complex Revenue Market Share by Application (2020-2025)
Table 16. Global Human Prothrombin Complex Sale Price by Application (2020-2025) & (M USD/Unit)
Table 17. Global Human Prothrombin Complex Sales by Company (2020-2025) & (K Units)
Table 18. Global Human Prothrombin Complex Sales Market Share by Company (2020-2025)
Table 19. Global Human Prothrombin Complex Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 21. Global Human Prothrombin Complex Sale Price by Company (2020-2025) & (M USD/Unit)
Table 22. Key Manufacturers Human Prothrombin Complex Producing Area Distribution and Sales Area
Table 23. Players Human Prothrombin Complex Products Offered
Table 24. Human Prothrombin Complex Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Human Prothrombin Complex Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Human Prothrombin Complex Sales Market Share Geographic Region (2020-2025)
Table 29. Global Human Prothrombin Complex Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Human Prothrombin Complex Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Human Prothrombin Complex Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Human Prothrombin Complex Sales Market Share by Country/Region (2020-2025)
Table 33. Global Human Prothrombin Complex Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Human Prothrombin Complex Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)
Table 36. Americas Human Prothrombin Complex Sales Market Share by Country (2020-2025)
Table 37. Americas Human Prothrombin Complex Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 39. Americas Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 40. APAC Human Prothrombin Complex Sales by Region (2020-2025) & (K Units)
Table 41. APAC Human Prothrombin Complex Sales Market Share by Region (2020-2025)
Table 42. APAC Human Prothrombin Complex Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 44. APAC Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 45. Europe Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)
Table 46. Europe Human Prothrombin Complex Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 48. Europe Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Prothrombin Complex Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Human Prothrombin Complex
Table 54. Key Market Challenges & Risks of Human Prothrombin Complex
Table 55. Key Industry Trends of Human Prothrombin Complex
Table 56. Human Prothrombin Complex Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Human Prothrombin Complex Distributors List
Table 59. Human Prothrombin Complex Customer List
Table 60. Global Human Prothrombin Complex Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Human Prothrombin Complex Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Human Prothrombin Complex Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Human Prothrombin Complex Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Human Prothrombin Complex Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Human Prothrombin Complex Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Human Prothrombin Complex Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Human Prothrombin Complex Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Human Prothrombin Complex Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Human Prothrombin Complex Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Human Prothrombin Complex Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Human Prothrombin Complex Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Human Prothrombin Complex Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Human Prothrombin Complex Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Takeda Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 75. Takeda Human Prothrombin Complex Product Portfolios and Specifications
Table 76. Takeda Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 77. Takeda Main Business
Table 78. Takeda Latest Developments
Table 79. CSL Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 80. CSL Human Prothrombin Complex Product Portfolios and Specifications
Table 81. CSL Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 82. CSL Main Business
Table 83. CSL Latest Developments
Table 84. Grifols Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 85. Grifols Human Prothrombin Complex Product Portfolios and Specifications
Table 86. Grifols Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 87. Grifols Main Business
Table 88. Grifols Latest Developments
Table 89. Octapharma Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 90. Octapharma Human Prothrombin Complex Product Portfolios and Specifications
Table 91. Octapharma Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 92. Octapharma Main Business
Table 93. Octapharma Latest Developments
Table 94. Hualan Biological Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 95. Hualan Biological Human Prothrombin Complex Product Portfolios and Specifications
Table 96. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 97. Hualan Biological Main Business
Table 98. Hualan Biological Latest Developments
Table 99. Meheco Xinxing Pharma Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors
Table 100. Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolios and Specifications
Table 101. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 102. Meheco Xinxing Pharma Main Business
Table 103. Meheco Xinxing Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Prothrombin Complex
Figure 2. Human Prothrombin Complex Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Prothrombin Complex Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Prothrombin Complex Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Prothrombin Complex Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Prothrombin Complex Sales Market Share by Country/Region (2024)
Figure 10. Human Prothrombin Complex Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 500 IU/Vial
Figure 12. Product Picture of 600 IU/Vial
Figure 13. Product Picture of 1000 IU/Vial
Figure 14. Product Picture of Others
Figure 15. Global Human Prothrombin Complex Sales Market Share by Type in 2025
Figure 16. Global Human Prothrombin Complex Revenue Market Share by Type (2020-2025)
Figure 17. Human Prothrombin Complex Consumed in Hemophilia B
Figure 18. Global Human Prothrombin Complex Market: Hemophilia B (2020-2025) & (K Units)
Figure 19. Human Prothrombin Complex Consumed in Vitamin K Deficiency
Figure 20. Global Human Prothrombin Complex Market: Vitamin K Deficiency (2020-2025) & (K Units)
Figure 21. Human Prothrombin Complex Consumed in Others
Figure 22. Global Human Prothrombin Complex Market: Others (2020-2025) & (K Units)
Figure 23. Global Human Prothrombin Complex Sale Market Share by Application (2024)
Figure 24. Global Human Prothrombin Complex Revenue Market Share by Application in 2025
Figure 25. Human Prothrombin Complex Sales by Company in 2025 (K Units)
Figure 26. Global Human Prothrombin Complex Sales Market Share by Company in 2025
Figure 27. Human Prothrombin Complex Revenue by Company in 2025 ($ millions)
Figure 28. Global Human Prothrombin Complex Revenue Market Share by Company in 2025
Figure 29. Global Human Prothrombin Complex Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Human Prothrombin Complex Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 32. Americas Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 33. APAC Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 34. APAC Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 35. Europe Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 36. Europe Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 39. Americas Human Prothrombin Complex Sales Market Share by Country in 2025
Figure 40. Americas Human Prothrombin Complex Revenue Market Share by Country (2020-2025)
Figure 41. Americas Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 42. Americas Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 43. United States Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Human Prothrombin Complex Sales Market Share by Region in 2025
Figure 48. APAC Human Prothrombin Complex Revenue Market Share by Region (2020-2025)
Figure 49. APAC Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 50. APAC Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 51. China Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 55. India Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Human Prothrombin Complex Sales Market Share by Country in 2025
Figure 59. Europe Human Prothrombin Complex Revenue Market Share by Country (2020-2025)
Figure 60. Europe Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 61. Europe Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 62. Germany Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 63. France Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Human Prothrombin Complex Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 70. Egypt Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Prothrombin Complex in 2025
Figure 76. Manufacturing Process Analysis of Human Prothrombin Complex
Figure 77. Industry Chain Structure of Human Prothrombin Complex
Figure 78. Channels of Distribution
Figure 79. Global Human Prothrombin Complex Sales Market Forecast by Region (2026-2031)
Figure 80. Global Human Prothrombin Complex Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Human Prothrombin Complex Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Human Prothrombin Complex Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Human Prothrombin Complex Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Human Prothrombin Complex Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Human Prothrombin Complex
Figure 2. Human Prothrombin Complex Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Prothrombin Complex Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Prothrombin Complex Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Prothrombin Complex Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Prothrombin Complex Sales Market Share by Country/Region (2024)
Figure 10. Human Prothrombin Complex Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 500 IU/Vial
Figure 12. Product Picture of 600 IU/Vial
Figure 13. Product Picture of 1000 IU/Vial
Figure 14. Product Picture of Others
Figure 15. Global Human Prothrombin Complex Sales Market Share by Type in 2025
Figure 16. Global Human Prothrombin Complex Revenue Market Share by Type (2020-2025)
Figure 17. Human Prothrombin Complex Consumed in Hemophilia B
Figure 18. Global Human Prothrombin Complex Market: Hemophilia B (2020-2025) & (K Units)
Figure 19. Human Prothrombin Complex Consumed in Vitamin K Deficiency
Figure 20. Global Human Prothrombin Complex Market: Vitamin K Deficiency (2020-2025) & (K Units)
Figure 21. Human Prothrombin Complex Consumed in Others
Figure 22. Global Human Prothrombin Complex Market: Others (2020-2025) & (K Units)
Figure 23. Global Human Prothrombin Complex Sale Market Share by Application (2024)
Figure 24. Global Human Prothrombin Complex Revenue Market Share by Application in 2025
Figure 25. Human Prothrombin Complex Sales by Company in 2025 (K Units)
Figure 26. Global Human Prothrombin Complex Sales Market Share by Company in 2025
Figure 27. Human Prothrombin Complex Revenue by Company in 2025 ($ millions)
Figure 28. Global Human Prothrombin Complex Revenue Market Share by Company in 2025
Figure 29. Global Human Prothrombin Complex Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Human Prothrombin Complex Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 32. Americas Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 33. APAC Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 34. APAC Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 35. Europe Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 36. Europe Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Human Prothrombin Complex Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Human Prothrombin Complex Revenue 2020-2025 ($ millions)
Figure 39. Americas Human Prothrombin Complex Sales Market Share by Country in 2025
Figure 40. Americas Human Prothrombin Complex Revenue Market Share by Country (2020-2025)
Figure 41. Americas Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 42. Americas Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 43. United States Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Human Prothrombin Complex Sales Market Share by Region in 2025
Figure 48. APAC Human Prothrombin Complex Revenue Market Share by Region (2020-2025)
Figure 49. APAC Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 50. APAC Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 51. China Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 55. India Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Human Prothrombin Complex Sales Market Share by Country in 2025
Figure 59. Europe Human Prothrombin Complex Revenue Market Share by Country (2020-2025)
Figure 60. Europe Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 61. Europe Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 62. Germany Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 63. France Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Human Prothrombin Complex Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Figure 70. Egypt Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Human Prothrombin Complex Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Prothrombin Complex in 2025
Figure 76. Manufacturing Process Analysis of Human Prothrombin Complex
Figure 77. Industry Chain Structure of Human Prothrombin Complex
Figure 78. Channels of Distribution
Figure 79. Global Human Prothrombin Complex Sales Market Forecast by Region (2026-2031)
Figure 80. Global Human Prothrombin Complex Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Human Prothrombin Complex Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Human Prothrombin Complex Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Human Prothrombin Complex Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Human Prothrombin Complex Revenue Market Share Forecast by Application (2026-2031)
